Jiafei Lin

649 total citations
15 papers, 491 citations indexed

About

Jiafei Lin is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Jiafei Lin has authored 15 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cell Biology and 4 papers in Immunology. Recurrent topics in Jiafei Lin's work include Hippo pathway signaling and YAP/TAZ (5 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (3 papers). Jiafei Lin is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (5 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (3 papers). Jiafei Lin collaborates with scholars based in China and United States. Jiafei Lin's co-authors include Jiayi Wang, Lifang Ma, Susu Guo, Fenyong Sun, Yueyue Yang, Qiuhui Pan, Yongxia Qiao, Gang Cai, Xiangfan Liu and Peihua Ni and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Jiafei Lin

15 papers receiving 489 citations

Peers

Jiafei Lin
Jiafei Lin
Citations per year, relative to Jiafei Lin Jiafei Lin (= 1×) peers Guang-Ang Tian

Countries citing papers authored by Jiafei Lin

Since Specialization
Citations

This map shows the geographic impact of Jiafei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiafei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiafei Lin more than expected).

Fields of papers citing papers by Jiafei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiafei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiafei Lin. The network helps show where Jiafei Lin may publish in the future.

Co-authorship network of co-authors of Jiafei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jiafei Lin. A scholar is included among the top collaborators of Jiafei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiafei Lin. Jiafei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Dong, Danfeng, et al.. (2022). Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5. FEBS Open Bio. 12(10). 1747–1760. 6 indexed citations
3.
Hou, Yanyan, Jiafei Lin, Danyang Wang, et al.. (2021). The circular RNA circ_GRHPR promotes NSCLC cell proliferation and invasion via interactions with the RNA‐binding protein PCBP2. Clinical and Experimental Pharmacology and Physiology. 48(8). 1171–1181. 13 indexed citations
4.
Yang, Yueyue, Jiafei Lin, Susu Guo, et al.. (2020). RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer. Cancer Cell International. 20(1). 587–587. 109 indexed citations
5.
Xue, Minghui, et al.. (2020). Inflammation accelerates copper‐mediated cytotoxicity through induction of six‐transmembrane epithelial antigens of prostate 4 expression. Immunology and Cell Biology. 99(4). 392–402. 23 indexed citations
6.
Xue, Minghui, et al.. (2019). Significance of increased IL-17-producing Foxp3+ Treg in peripheral blood of patients with active systemic lupus erythematosus. Zhonghua weishengwuxue he mianyixue zazhi. 39(3). 174–179. 1 indexed citations
7.
Liu, Ya, Xiao Zhang, Jiafei Lin, et al.. (2019). CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. Cell Death and Disease. 10(9). 644–644. 81 indexed citations
8.
Lin, Jiafei, Yingwei Zhang, Jiemin Wu, et al.. (2018). Neuropilin 1 (NRP1) is a novel tumor marker in hepatocellular carcinoma. Clinica Chimica Acta. 485. 158–165. 35 indexed citations
9.
Li, Lei, Liang Hu, Jiafei Lin, et al.. (2016). Hepatic expansion of virus-specific CD8+BTLA+ T cells with regulatory properties in chronic hepatitis B virus infection. Cellular Immunology. 311. 36–45. 17 indexed citations
10.
Ma, Lifang, Jiafei Lin, Yongxia Qiao, et al.. (2015). Serum CD166: A novel hepatocellular carcinoma tumor marker. Clinica Chimica Acta. 441. 156–162. 16 indexed citations
11.
Liu, Xiangfan, Ling Yao, Changqiang Chen, et al.. (2014). New Insights into FAK Phosphorylation Based on a FAT Domain-Defective Mutation. PLoS ONE. 9(9). e107134–e107134. 14 indexed citations
12.
Ma, Lifang, Jiayi Wang, Jiafei Lin, et al.. (2014). Cluster of Differentiation 166 (CD166) Regulated by Phosphatidylinositide 3-Kinase (PI3K)/AKT Signaling to Exert Its Anti-apoptotic Role via Yes-associated Protein (YAP) in Liver Cancer. Journal of Biological Chemistry. 289(10). 6921–6933. 49 indexed citations
13.
Cai, Gang, Lei Li, Liang Hu, et al.. (2013). B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function. Journal of Gastroenterology. 48(12). 1362–1372. 22 indexed citations
14.
Cai, Gang, et al.. (2012). A Regulatory Role for IL-10 Receptor Signaling in Development and B Cell Help of T Follicular Helper Cells in Mice. The Journal of Immunology. 189(3). 1294–1302. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026